Breast Cancer

Metabolic syndrome scores and obesity appeared linked in different ways to breast cancer incidence and mortality among postmenopausal women, according to findings published in Cancer.

Federally qualified health centers reported substantially lower breast, cervical and colorectal cancer screenings compared with the general U.S. population, highlighting a gap in screening rates for adults from underrepresented groups.

Women with newly diagnosed breast cancer who consumed a heart-healthy diet at the time of their diagnosis had a lower risk for developing heart disease, results from a prospective study published in JNCI Cancer Spectrum showed.

Racial and ethnic minorities with breast cancer had a higher likelihood of declining various treatment options than white patients in the past 2 decades, results from a retrospective study published in JAMA Network Open showed.

A recent survey from Women Living Better revealed that 63% of midlife women reported “not feeling like myself” half the time or more over 3 months.

Screenings for breast, cervical and colorectal cancers were significantly lower in federally qualified health centers compared with the general population, a study in JAMA Internal Medicine showed.

Bulk ordering and text messaging outreach significantly increased completion rates for mammography breast cancer screening, according to results of two randomized clinical trials published in JAMA Internal Medicine.

In this episode, host Shikha Jain, MD, speaks with Sean Bohen, MD, about how cancer therapies are changing how oncology can be discussed, shifting from clinical to industry work and more.

The FDA has approved trastuzumab-strf as a biosimilar to trastuzumab for the treatment of certain patients with HER2-overexpressing malignancies, according to a press release from the agent’s manufacturer.

Women should be screened for breast cancer every other year starting at age 40 years, according to a new recommendation statement from the U.S. Preventive Services Task Force.